Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0480
-0.0010 (-2.04%)
Aug 7, 2026, 11:41 AM AEST
Microba Life Sciences Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 14.9 | 15.67 | 12.09 | 5.42 | 4.69 | 3.73 |
Revenue Growth | -4.88% | 29.60% | 123.06% | 15.60% | 25.62% | 28.31% |
Gross Profit Gross Profit Growth | 6.97 | 7.44 | 5.91 | 2.68 | 2.37 | 2.04 |
Operating Income Operating Income Growth | -24.51 | -24.61 | -25.84 | -20.23 | -16.27 | -9.52 |
Net Income Net Income Growth | -19.75 | -14.94 | -19.94 | -12.68 | -11.47 | -7.52 |
Earnings Per Share EPS Growth | -0.04 | -0.03 | -0.05 | -0.04 | -0.05 | -0.04 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Australia Australia Growth | 5.99 | 5.41 | 4.2 | 3.16 | 2.62 | 2.01 |
Europe Europe Growth | 1.12 | 1.37 | 1.77 | 1.08 | 0.77 | 0.41 |
New Zealand New Zealand Growth | 0 | 0.01 | 0.13 | 0.16 | 0.26 | 0.25 |
United Arab Emirates United Arab Emirates Growth | 0.15 | 0.1 | 0.66 | 0.46 | 0.27 | - |
United Kingdom United Kingdom Growth | 6.8 | 7.54 | 4.53 | 0 | 0 | 0.08 |
United States United States Growth | 0.59 | 0.94 | 0.6 | 0.55 | 0.77 | 0.97 |
Ireland Ireland Growth | 0.22 | 0.29 | 0.17 | - | - | - |
Asia Asia Growth | - | 0.01 | 0.02 | 0 | - | - |
Total Total Growth | 14.9 | 15.67 | 12.09 | 5.42 | 4.69 | 3.73 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 11.27 | 11.88 | 21.09 | 32.25 | 30.79 | 13.03 |
Total Debt Total Debt Growth | 2.54 | 3.23 | 1.58 | 1.14 | 1.33 | 0.27 |
Net Cash (Debt) Net Cash Growth | 8.73 | 8.65 | 19.51 | 31.11 | 29.46 | 12.76 |
Net Cash Growth | 1.00% | -55.69% | -37.28% | 5.60% | 130.88% | 101.46% |
Net Cash Per Share Net Cash Per Share Growth | 0.02 | 0.02 | 0.05 | 0.10 | 0.13 | 0.07 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -15.05 | -12.01 | -15.57 | -12.39 | -10.45 | -7.18 |
Capital Expenditures CapEx Growth | -0.34 | -0.33 | -1.49 | -0.55 | -1.64 | -0.25 |
Free Cash Flow Free Cash Flow Growth | -15.38 | -12.34 | -17.05 | -12.94 | -12.08 | -7.43 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 46.77% | 47.49% | 48.84% | 49.41% | 50.46% | 54.61% |
Operating Margin | -164.43% | -157.05% | -213.71% | -373.24% | -347.05% | -255.09% |
Pretax Margin | -134.00% | -96.02% | -165.34% | -233.84% | -244.45% | -201.58% |
Profit Margin | -132.53% | -95.34% | -164.92% | -233.95% | -244.64% | -201.58% |
FCF Margin | -103.22% | -78.75% | -141.06% | -238.82% | -257.75% | -199.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PS Ratio | 2.31 | 2.79 | 5.93 | 19.05 | 11.70 | - |